Literature DB >> 8605919

Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells.

U M Abdel-Motal1, L Berg, A Rosén, M Bengtsson, C J Thorpe, J Kihlberg, J Dahmén, G Magnusson, K A Karlsson, M Jondal.   

Abstract

Cytotoxic T cells (CTL) recognize target proteins as short peptides presented by major histocompatibility complex (MHC) class I restriction elements. However, there is also evidence for peptide-independent T cell receptor (TCR) recognition of target proteins and non-protein structures. How such T cell responses are generated is presently unclear. We generated carbohydrate (CHO)-specific, MHC-unrestricted CTL responses by coupling di- and trisaccharides to Kb- or Db-binding peptides for direct immunization in mice. Four peptides and three CHO have been analyzed with the CHO either in terminal or central position on the carrier peptide. With two of these glycopeptides, with galabiose (Gal alpha 1-4Gal; Gal2) bound to a homocysteine (via an ethylene spacer arm) in position 4 or 6 in a vesicular stomatitis virus nucleoprotein-derived peptide (RGYVYQGL binding to Kb), CTL were generated which preferentially killed target cells treated with glycopeptide compared to those treated with the core peptide. Polyclonal CTL were also found to kill target cells expressing the same Gal2 epitope in a glycolipid. By fractionation of CTL, preliminary data indicate that glycopeptide-specific Kb-restricted CTL and unrestricted CHO-specific CTL belong to different T cell populations with regard to TCR expression. The results demonstrate that hapten-specific unrestricted CTL responses can be generated with MHC class I-binding carrier peptides. Different models that might explain the generation of such responses are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605919     DOI: 10.1002/eji.1830260307

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  24 in total

Review 1.  Tissue distribution, antigen specificity and effector functions of gamma delta T cells in human diseases.

Authors:  G De Libero
Journal:  Springer Semin Immunopathol       Date:  2000

2.  A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor.

Authors:  Vasso Apostolopoulos; Elizabeth Yuriev; Paul A Ramsland; Jodie Halton; Carla Osinski; Wenjun Li; Magdalena Plebanski; Hans Paulsen; Ian F C McKenzie
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

3.  Processing of glycans on glycoprotein and glycopeptide antigens in antigen-presenting cells.

Authors:  Ole Werdelin; Morten Meldal; Teis Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

4.  The effect of haptens on protein-carrier immunogenicity.

Authors:  Tal Gefen; Jacob Vaya; Soliman Khatib; Irena Rapoport; Meital Lupo; Eilon Barnea; Arie Admon; Elimelech Dan Heller; Elina Aizenshtein; Jacob Pitcovski
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

5.  Convergent synthesis of neoglycopeptides by coupling of 2-bromoethyl glycosides to cysteine and homocysteine residues in T cell stimulating peptides.

Authors:  M Bengtsson; J Broddefalk; J Dahmén; K Henriksson; J Kihlberg; H Lönn; B R Srinivasa; K Stenvall
Journal:  Glycoconj J       Date:  1998-03       Impact factor: 2.916

Review 6.  Dendritic cells in antifungal immunity and vaccine design.

Authors:  René M Roy; Bruce S Klein
Journal:  Cell Host Microbe       Date:  2012-05-17       Impact factor: 21.023

Review 7.  Carbohydrates as T-cell antigens with implications in health and disease.

Authors:  Lina Sun; Dustin R Middleton; Paeton L Wantuch; Ahmet Ozdilek; Fikri Y Avci
Journal:  Glycobiology       Date:  2016-05-28       Impact factor: 4.313

8.  Extended O-GlcNAc on HLA Class-I-Bound Peptides.

Authors:  Fabio Marino; Marshall Bern; Geert P M Mommen; Aneika C Leney; Jacqueline A M van Gaans-van den Brink; Alexandre M J J Bonvin; Christopher Becker; Cécile A C M van Els; Albert J R Heck
Journal:  J Am Chem Soc       Date:  2015-08-19       Impact factor: 15.419

Review 9.  Bridging innate and adaptive antitumor immunity targeting glycans.

Authors:  Anastas Pashov; Bejatolah Monzavi-Karbassi; Gajendra P S Raghava; Thomas Kieber-Emmons
Journal:  J Biomed Biotechnol       Date:  2010-06-15

Review 10.  Specificity in cancer immunotherapy.

Authors:  Andrea Schietinger; Mary Philip; Hans Schreiber
Journal:  Semin Immunol       Date:  2008-08-05       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.